(Q38569137)

4 September 2017

1 reference

title

Infection caused by Mycobacterium tuberculosis (English)

1 reference

Mycobacterium tuberculosis

4 September 2017

1 reference

C A Peloquin

1

1 reference

PubMed ID

8123968

4 September 2017

S E Berning

series ordinal

2

1 reference

PubMed ID

8123968

4 September 2017

language of work or name

English

0 references

publication date

1 January 1994

1 reference

Annals of Pharmacotherapy

4 September 2017

1 reference

4 September 2017

28

1 reference

4 September 2017

1

1 reference

4 September 2017

72-84

1 reference

New reports make recommendations, ask for resources to stem TB epidemic

4 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Tuberculosis: commentary on a reemergent killer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Ten-year experience with artificial pneumoperitoneum for end-stage, drug-resistant pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

The historical decline of tuberculosis in Europe and America: its causes and significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

The impact of human immunodeficiency virus infection on tuberculosis and its control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Clinical Presentation and Outcome of Patients with HIV Infection and Tuberculosis Caused by Multiple-Drug-resistant Bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Pulse dosing versus continuous infusion of antibiotics. Pharmacokinetic-pharmacodynamic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Once-daily aminoglycoside therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Pharmacokinetics of rifabutin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Oxazolidinones, a new class of synthetic antituberculosis agent in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Liposomes as carriers of antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Sustained release of isoniazid in vivo from a single implant of a biodegradable polymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

The use of rifampicin and isoniazid entrapped in liposomes for the treatment of Murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

A leap of faith. What can we do to curtail intrainstitutional transmission of tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

When tuberculosis treatment fails. A social behavioral account of patient adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

Intravenous streptomycin use in a patient infected with high-level, gentamicin-resistant Streptococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809402800115

10.1177/106002809402800115

21 January 2018

Identifiers

DOI

1 reference

4 September 2017

1 reference

PubMed ID

8123968